Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1175751.RASNk_G7nUQ-CwcAYKSdjt4xZLRADm7SjFV-MZ7HxTxRc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1175751.RASNk_G7nUQ-CwcAYKSdjt4xZLRADm7SjFV-MZ7HxTxRc130_assertion type Assertion NP1175751.RASNk_G7nUQ-CwcAYKSdjt4xZLRADm7SjFV-MZ7HxTxRc130_head.
- NP1175751.RASNk_G7nUQ-CwcAYKSdjt4xZLRADm7SjFV-MZ7HxTxRc130_assertion description "[The amounts of Wnt2b, Fzd5 and ?-catenin mRNA and protein were significantly greater in form-deprived myopia eyes than in control eyes.DKK-1 (antagonist) reduced the myopic shift in refractive error and increase in axial elongation, whereas Norrin had the opposite effect in FDM eyes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1175751.RASNk_G7nUQ-CwcAYKSdjt4xZLRADm7SjFV-MZ7HxTxRc130_provenance.
- NP1175751.RASNk_G7nUQ-CwcAYKSdjt4xZLRADm7SjFV-MZ7HxTxRc130_assertion evidence source_evidence_literature NP1175751.RASNk_G7nUQ-CwcAYKSdjt4xZLRADm7SjFV-MZ7HxTxRc130_provenance.
- NP1175751.RASNk_G7nUQ-CwcAYKSdjt4xZLRADm7SjFV-MZ7HxTxRc130_assertion SIO_000772 24755605 NP1175751.RASNk_G7nUQ-CwcAYKSdjt4xZLRADm7SjFV-MZ7HxTxRc130_provenance.
- NP1175751.RASNk_G7nUQ-CwcAYKSdjt4xZLRADm7SjFV-MZ7HxTxRc130_assertion wasDerivedFrom befree-2016 NP1175751.RASNk_G7nUQ-CwcAYKSdjt4xZLRADm7SjFV-MZ7HxTxRc130_provenance.
- NP1175751.RASNk_G7nUQ-CwcAYKSdjt4xZLRADm7SjFV-MZ7HxTxRc130_assertion wasGeneratedBy ECO_0000203 NP1175751.RASNk_G7nUQ-CwcAYKSdjt4xZLRADm7SjFV-MZ7HxTxRc130_provenance.